| Bladder cancer: epidemiology, staging and grading, and diagnosis Z Kirkali, T Chan, M Manoharan, F Algaba, C Busch, L Cheng, ... Urology 66 (6), 4-34, 2005 | 1349 | 2005 |
| The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia JR Srigley, B Delahunt, JN Eble, L Egevad, JI Epstein, D Grignon, O Hes, ... The American journal of surgical pathology 37 (10), 1469-1489, 2013 | 1238 | 2013 |
| 2004 WHO classification of the renal tumors of the adults A Lopez-Beltran, M Scarpelli, R Montironi, Z Kirkali European urology 49 (5), 798-805, 2006 | 1126 | 2006 |
| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012 | 944 | 2012 |
| p63 is a prostate basal cell marker and is required for prostate development S Signoretti, D Waltregny, J Dilks, B Isaac, D Lin, L Garraway, A Yang, ... The American journal of pathology 157 (6), 1769-1775, 2000 | 787 | 2000 |
| The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters B Delahunt, JC Cheville, G Martignoni, PA Humphrey, C Magi-Galluzzi, ... The American journal of surgical pathology 37 (10), 1490-1504, 2013 | 772 | 2013 |
| Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers GP Paner, WM Stadler, DE Hansel, R Montironi, DW Lin, MB Amin European urology 73 (4), 560-569, 2018 | 549 | 2018 |
| The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation C De Nunzio, G Kramer, M Marberger, R Montironi, W Nelson, F Schröder, ... European urology 60 (1), 106-117, 2011 | 524 | 2011 |
| Her-2-neu expression and progression toward androgen independence in human prostate cancer S Signoretti, R Montironi, J Manola, A Altimari, C Tam, G Bubley, S Balk, ... Journal of the National Cancer Institute 92 (23), 1918-1925, 2000 | 479 | 2000 |
| Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System) V Panebianco, Y Narumi, E Altun, BH Bochner, JA Efstathiou, S Hafeez, ... European urology 74 (3), 294-306, 2018 | 467 | 2018 |
| Prognostic factors in prostate cancer: College of American Pathologists consensus statement 1999 DG Bostwick, DJ Grignon, MEH Hammond, MB Amin, M Cohen, ... Archives of pathology & laboratory medicine 124 (7), 995-1000, 2000 | 461 | 2000 |
| PD-1 blockade therapy in renal cell carcinoma: current studies and future promises F Massari, M Santoni, C Ciccarese, D Santini, S Alfieri, G Martignoni, ... Cancer treatment reviews 41 (2), 114-121, 2015 | 455 | 2015 |
| Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine L Cheng, A Lopez-Beltran, F Massari, GT MacLennan, R Montironi Modern Pathology 31 (1), 24-38, 2018 | 438 | 2018 |
| Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature V Scattoni, A Zlotta, R Montironi, C Schulman, P Rigatti, F Montorsi European urology 52 (5), 1309-1322, 2007 | 438 | 2007 |
| The role of focal therapy in the management of localised prostate cancer: a systematic review M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ... European urology 66 (4), 732-751, 2014 | 424 | 2014 |
| Positive surgical margins after radical prostatectomy: a systematic review and contemporary update O Yossepowitch, A Briganti, JA Eastham, J Epstein, M Graefen, ... European urology 65 (2), 303-313, 2014 | 398 | 2014 |
| The contemporary concept of significant versus insignificant prostate cancer G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ... European urology 60 (2), 291-303, 2011 | 362 | 2011 |
| Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens JI Epstein, M Amin, L Boccon-Gibod, L Egevad, PA Humphrey, G Mikuz, ... Scandinavian journal of urology and nephrology 39 (sup216), 34-63, 2005 | 325 | 2005 |
| The 2004 WHO classification of bladder tumors: a summary and commentary R Montironi, A Lopez-Beltran International journal of surgical pathology 13 (2), 143-153, 2005 | 318 | 2005 |
| Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level T Karantanos, CP Evans, B Tombal, TC Thompson, R Montironi, ... European urology 67 (3), 470-479, 2015 | 315 | 2015 |
